BONOTHYRK

BONOTHYRK® is a complex of peptide fractions received from parathyroid young animals. The dedicated peptides have a selective action on the parathyroid cells, normalising metabolism and improving functional activity. BONOTHYRK® effect was proven in various clinical studies. It restores the parathyroid functional activity in cases related to hyperparathyroidism, osteoporosis, deossification, urolithiasis, muscle weakness, hypocalcemia, numbness and muscle spasms.

Usage:
• Osteoporosis
• Deossification and urolithiasis
• Muscle weakness, parathyroid hyperplasia
• Numbness and muscle spasms, caused by hypocalcemia

Ingredients:
peptide complex A-21 (peptide of parathyroids), microcrystalline cellulose (E460, the flowing agent), gelatin (encapsulating agent), sugar beet (binding filler), lactose (excipient-humectant), starch (stabilizer), tween-80 (emulsifier), titanium dioxide (E171, coloring agent for capsules).

Daily dose contains (2 capsules): 20 mg of peptide complex A-21.

Dosage:
Adults: 1-2 capsules, 1-2 times daily before meal, for 1 month.
It is advisable to repeat the course in 3-6 months for the best results.

Form release:
60 capsules of 0.2 g